ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,2,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
9,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,1,Headache,Headaches NEC,Headaches,Nerv,N
11,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,2,Headache,Headaches NEC,Headaches,Nerv,N
12,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Headache,Headaches NEC,Headaches,Nerv,N
13,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
13,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
13,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
13,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Headache,Headaches NEC,Headaches,Nerv,N
15,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
17,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,1,Headache,Headaches NEC,Headaches,Nerv,N
19,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
19,3,Headache,Headaches NEC,Headaches,Nerv,N
19,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
19,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
21,1,Headache,Headaches NEC,Headaches,Nerv,N
22,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
22,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
22,3,Headache,Headaches NEC,Headaches,Nerv,N
22,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
22,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
24,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
27,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,2,Headache,Headaches NEC,Headaches,Nerv,N
28,1,Headache,Headaches NEC,Headaches,Nerv,N
28,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
28,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,4,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
29,1,Headache,Headaches NEC,Headaches,Nerv,N
30,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,2,Headache,Headaches NEC,Headaches,Nerv,N
30,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
31,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
31,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
32,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,2,Headache,Headaches NEC,Headaches,Nerv,N
32,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
33,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
33,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
33,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,1,Headache,Headaches NEC,Headaches,Nerv,N
35,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
36,1,Headache,Headaches NEC,Headaches,Nerv,N
36,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
38,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
38,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
40,1,Headache,Headaches NEC,Headaches,Nerv,N
41,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
41,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Headache,Headaches NEC,Headaches,Nerv,N
43,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
43,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
44,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
44,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
45,1,Headache,Headaches NEC,Headaches,Nerv,N
46,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
48,3,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
49,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
50,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,1,Headache,Headaches NEC,Headaches,Nerv,N
52,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
53,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
53,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,3,Headache,Headaches NEC,Headaches,Nerv,N
53,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
54,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
55,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
56,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
60,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
61,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
62,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
64,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
65,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
65,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
67,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
69,1,Headache,Headaches NEC,Headaches,Nerv,N
70,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
70,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
71,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,2,Headache,Headaches NEC,Headaches,Nerv,N
75,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
76,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
77,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
77,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
78,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
79,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
81,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
81,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
82,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
82,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
84,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
85,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
87,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
87,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
88,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
89,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
90,2,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
90,3,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
90,4,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
90,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
90,6,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
90,8,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,9,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
91,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
92,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
93,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
93,2,Eschar,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
94,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
95,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
95,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
95,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
96,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
96,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
96,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
96,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
98,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
99,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
99,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
100,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
100,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,3,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
101,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
101,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
101,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
101,5,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
101,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,10,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,11,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
101,12,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,13,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,14,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
102,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
102,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
102,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
103,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
103,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
104,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
104,2,Auricular swelling,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
104,3,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
104,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
104,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
104,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,11,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
104,12,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
105,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
105,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
105,3,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
105,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
105,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
105,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,7,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
106,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
106,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
106,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
106,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
106,6,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
106,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
106,8,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
106,9,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,10,Headache,Headaches NEC,Headaches,Nerv,N
106,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
106,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
106,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,14,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
106,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
107,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
107,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
107,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
107,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
108,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
108,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
108,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
108,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
108,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
108,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
108,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,8,Somatic symptom disorder of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
108,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
109,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
109,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
109,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
109,4,Eyelid bleeding,Lid bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
109,5,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
109,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
109,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
109,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
109,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,11,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
110,1,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
111,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
111,2,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
112,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,2,Headache,Headaches NEC,Headaches,Nerv,N
113,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
113,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
114,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
115,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
116,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
116,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
116,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
116,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
116,5,Application site scab,Application site reactions,Administration site reactions,Genrl,N
116,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
116,7,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
116,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
116,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
117,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
118,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
119,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
119,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
120,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
120,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
120,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
120,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
120,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
120,6,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
120,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
120,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
120,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
121,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
121,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
121,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
122,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
122,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
123,1,Upper respiratory tract inflammation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
124,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
124,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,1,Oral mucosa erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
126,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
126,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,3,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
126,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,5,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
126,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
127,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
128,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
128,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
128,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
128,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
129,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
129,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
129,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
130,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,2,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
131,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
131,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
131,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
132,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
132,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
132,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
132,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
132,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
132,7,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
133,1,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
134,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
134,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
135,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
135,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
136,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
136,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
136,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
137,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
137,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
138,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
138,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
138,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
138,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
138,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
138,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,11,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
139,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,1,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
141,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
141,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
141,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
142,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
142,2,Application site mass,Application site reactions,Administration site reactions,Genrl,N
142,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
142,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
142,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
142,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
142,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
143,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
143,3,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
144,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
145,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
145,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
146,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
146,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
146,4,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
147,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
148,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
148,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
148,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
148,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
149,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
149,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
149,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
150,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
150,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
151,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
152,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
158,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
161,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
161,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
161,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
162,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
163,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
163,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
163,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
163,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
163,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
164,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
166,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
166,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
167,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
167,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
167,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
167,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
167,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
167,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
167,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
167,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
168,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
169,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
169,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
169,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
169,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
169,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
170,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
170,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
170,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
171,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
171,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
171,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
172,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
173,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
173,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
173,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
173,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
174,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
174,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
175,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
175,3,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
175,4,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
176,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
176,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
177,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
177,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
179,2,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
179,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
180,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
180,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
181,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
182,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
183,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
184,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
185,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
185,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
187,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
187,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
188,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,2,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
188,3,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
188,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
188,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,2,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
189,3,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
189,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
189,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,1,Administration site discolouration,Administration site reactions NEC,Administration site reactions,Genrl,N
191,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
191,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
191,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
191,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
191,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
191,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
191,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
193,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
193,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
193,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
194,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
194,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
195,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
195,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
196,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
197,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
198,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
199,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,4,Vaccination site bruising,Vaccination site reactions,Administration site reactions,Genrl,N
200,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
200,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
200,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
201,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
201,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
201,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
202,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
202,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
202,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
202,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
202,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
202,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
202,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
202,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
202,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
203,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
204,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
204,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
205,1,Drug-disease interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
206,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
206,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
207,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
207,2,Unintentional use for unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
208,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
210,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
210,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
210,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
211,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
212,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
213,1,Circumoral swelling,Angioedemas,Angioedema and urticaria,Skin,N
213,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
214,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
215,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
216,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
216,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
217,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
217,2,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
218,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
218,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
218,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
219,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
220,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
220,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,1,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
221,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
221,3,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
221,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
222,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
223,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
223,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
224,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
224,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
224,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
224,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
225,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
225,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
225,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
226,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
226,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
226,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
227,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
227,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
228,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
231,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
232,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
233,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
233,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
234,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
234,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
235,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
236,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
236,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
236,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
236,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
236,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
237,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
238,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
238,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
239,1,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
240,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
241,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
242,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
242,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
242,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
244,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
244,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
246,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
246,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
248,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
248,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
249,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
252,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
252,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
254,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
254,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
255,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
255,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
255,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
256,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
